Journal
ADVANCES IN CHRONIC KIDNEY DISEASE
Volume 21, Issue 1, Pages 96-105Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ackd.2013.08.007
Keywords
Hematopoietic stem cell transplant; Acute kidney injury; Chronic kidney disease; End-stage renal disease; Kidney transplantation
Categories
Ask authors/readers for more resources
Hematopoietic stem cell transplant (HSCT) patients are at risk for acute kidney disease and CKD, which confer excess morbidity and mortality in this patient population. A main cause of acute kidney injury (AKI) in stem cell recipients is prerenal azotemia, but acute tubular necrosis (ATN), obstruction, marrow transfusion toxicity, and hepatic sinusoidal obstruction syndrome also contribute. AKI is an important risk factor for death and CKD among HSCT survivors. CKD is a growing complication of HSCT as more patients are transplanted and survival improves. For most patients, the exact etiology of CKD is never identified, but graft vs host disease and thrombotic microangiopathy are important diagnoses to consider. Stem cell transplant patient survival on dialysis is generally poor, but kidney transplantation is a safe and reasonable option for HSCT recipients who progress to ESRD. (C) 2014 by the National Kidney Foundation, Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available